We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

A. Menarini Diagnostics S.r.l.

A. Menarini Diagnostics S.r.l. is fully committed to developing high tech diagnostics instruments and reagents to imp... read more Featured Products: More products

Download Mobile App





Menarini Introduces PRIME MDx All-in-One Molecular Diagnostics Solution

By LabMedica International staff writers
Posted on 23 May 2023

Menarini Diagnostics (Florence, Italy) is presenting its range of innovative professional diagnostics solutions in the field of molecular diagnostics, autoimmunity testing, hemoglobin analysis, and immunoassay testing at EuroMedLab Rome 2023. More...

The main highlight at Menarini's booth during this industry event is the brand new PRIME MDx all-in-one solution. This fully automated sample-to-result system is specifically designed to streamline laboratory workflows for real-time PCR diagnostic assays, offering exceptional efficiency, flexibility, and ease of use. With its automation and guided instrument setup, PRIME MDx minimizes manual intervention and ensures full sample traceability. Dedicated software enables automatic result generation and interpretation, leading to high-quality results, workflow standardization, and improved laboratory efficiency. The continuous workflow feature allows users to initiate a new loading process (extraction/setup) while a previous PCR is still running. PRIME MDx offers the flexibility to manage runs with various extraction reagent formats (prefilled or standard) and seamlessly integrates with existing IT infrastructure.

At the 2023 WordLab-EuroMedLab Congress, Menarini is also presenting the Zenit range of high-throughput innovations. This includes the Zenit PRIME random access chemiluminescence analyzer, catering to the autoimmunity laboratory's needs with its comprehensive panel of reagents and advanced features. The walk-away system boasts a throughput of up to 120 tests/hour, with continuous loading and random access to samples, specific and common reagents, and consumables, enabling efficient operation within an 8-hour timeframe (1000 tests).

In addition, Menarini is showcasing the winning combination of Zenit flow and Zenit fast in IIF (Indirect Immunofluorescence) slide processing and scanning. The Zenit flow automated IIF slide processor performs all necessary steps, from sample dilution to coverslip mounting, resulting in improved standardization and a flexible, optimized workflow within the laboratory. The Zenit flow is complimented by the Zenit fast automated diagnostics system for the acquisition, analysis, and storage of IFA (Immunofluorescence Assay) slides. It provides laboratories with an efficient solution to enhance the management of IFA tests, standardize the validation procedure, and reduce intra- and inter-laboratory variability. Some noteworthy features of Zenit fast include image autofocusing technology, whole-well scanning capability, software algorithms for IFA detection and pattern recognition, run-time efficiency, recognition of various ANA (Antinuclear Antibody) IFA patterns, and the ability to analyze different IFA substrates.

Related Links:
Menarini Diagnostics 


Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Biochemistry Analyzer
Chemi+ 8100
New
Uric Acid Meter
PA-16
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.